Medtronic plcMDT
時価総額
$1296.6億
PER
医療機器・治療デバイス分野の米国最大手。脳血管用コイルやステント、脊髄・脳刺激装置、MiniMed 780Gなどを展開。2025年5月に糖尿病事業の分社化計画発表、2024年2月に人工呼吸器事業撤退。150カ国超で米国・欧州・中国・日本を中心に展開。
| 2015年 4月24日 | 2016年 4月29日 | 2017年 4月28日 | 2018年 4月27日 | 2019年 4月26日 | 2020年 4月24日 | 2021年 4月30日 | 2022年 4月29日 | 2023年 4月28日 | 2024年 4月26日 | 2025年 4月25日 | |
| Cash and cash equivalents | 4,843 | 2,876 | 4,967 | 3,669 | 4,393 | 4,140 | 3,593 | 3,714 | 1,543 | 1,284 | 2,218 |
| Investments | 14,637 | 9,758 | 8,741 | 7,558 | 5,455 | 6,808 | 7,224 | 6,859 | 6,416 | 6,721 | 6,747 |
| Accounts Receivable, after Allowance for Credit Loss, Current | 5,112 | 5,562 | 5,591 | 5,987 | 6,222 | 4,645 | 5,462 | 5,551 | 5,998 | 6,128 | 6,515 |
| Inventories | 3,463 | 3,473 | 3,338 | 3,579 | 3,753 | 4,229 | 4,313 | 4,616 | 5,293 | 5,217 | 5,476 |
| Other current assets | - | - | - | 2,187 | 2,144 | 2,209 | 1,955 | 2,318 | 2,425 | 2,584 | 2,858 |
| Total current assets | 30,844 | 23,600 | 24,873 | 22,980 | 21,967 | 22,031 | 22,548 | 23,059 | 21,675 | 21,935 | 23,814 |
| Property, Plant and Equipment, Net | 4,699 | 4,841 | 4,361 | 4,604 | 4,675 | 4,828 | 5,221 | - | - | 6,131 | 6,837 |
| Goodwill | 40,530 | 41,500 | 38,515 | 39,543 | 39,959 | 39,841 | 41,961 | 40,502 | 41,425 | 40,986 | 41,737 |
| Other intangible assets, net | 28,101 | 26,899 | 23,407 | 21,723 | 20,560 | 19,063 | 17,740 | 15,595 | 14,844 | 13,225 | 11,667 |
| Tax assets | - | - | 1,509 | 1,465 | 1,519 | 2,832 | 3,169 | 3,403 | 3,477 | 3,657 | 4,040 |
| Other assets | 1,737 | 1,559 | 1,232 | 1,078 | 1,014 | 2,094 | 2,443 | 3,008 | 3,959 | 4,047 | 3,584 |
| Total assets | 106,685 | 99,782 | 99,816 | 91,393 | 89,694 | 90,689 | 93,083 | 90,981 | 90,948 | 89,981 | 91,680 |
| Debt, Current | 2,434 | 993 | 7,520 | 2,058 | 838 | 2,776 | 11 | 3,742 | 20 | 1,092 | 2,874 |
| Accounts payable | 1,610 | 1,709 | 1,731 | 1,628 | 1,953 | 1,996 | 2,106 | 2,276 | 2,662 | 2,410 | 2,449 |
| Accrued compensation | 1,611 | 1,712 | 1,860 | 1,988 | 2,189 | 2,099 | 2,482 | 2,121 | 1,949 | 2,375 | 2,514 |
| Accrued income taxes | 935 | 566 | 633 | 979 | 567 | 502 | 435 | 704 | 840 | 1,330 | 1,358 |
| Other accrued expenses | 2,464 | 2,185 | 2,442 | 3,431 | 2,925 | 2,993 | 3,475 | 3,551 | 3,581 | 3,582 | 3,683 |
| Total current liabilities | 9,173 | 7,165 | 14,220 | 10,084 | 8,472 | 10,366 | 8,509 | 12,394 | 9,051 | 10,789 | 12,879 |
| Long-term debt | 33,752 | 30,247 | 25,921 | 23,699 | 24,486 | 22,021 | 26,378 | 20,372 | 24,344 | 23,932 | 25,642 |
| Liability, Defined Benefit Plan, Noncurrent | 1,535 | 1,759 | 1,641 | 1,425 | 1,651 | 1,910 | 1,557 | 1,113 | 1,093 | 1,101 | 1,158 |
| Accrued income taxes | 2,476 | 2,903 | 2,405 | 3,051 | 2,838 | 2,682 | 2,251 | 2,087 | 2,360 | 1,859 | 1,574 |
| Deferred tax liabilities | - | - | 2,978 | 1,423 | 1,278 | 1,174 | 1,028 | 884 | 708 | 515 | 403 |
| Other liabilities | 1,819 | 1,916 | 1,515 | 889 | 757 | 1,664 | 1,756 | 1,410 | 1,727 | 1,365 | 1,769 |
| Total liabilities | 53,455 | 47,719 | 49,400 | 40,571 | 39,482 | 39,817 | 41,481 | 38,260 | 39,283 | 39,561 | 43,424 |
| Common Stock, Value, Issued | - | - | - | - | - | - | - | - | - | - | - |
| Additional paid-in capital | - | - | 29,551 | 28,127 | 26,532 | 26,165 | 26,319 | 24,566 | 24,590 | 23,129 | 20,833 |
| Retained earnings | 54,414 | 53,931 | 23,356 | 24,379 | 26,270 | 28,132 | 28,594 | 30,250 | 30,392 | 30,403 | 31,476 |
| Accumulated other comprehensive loss | -1,184 | -1,868 | -2,613 | -1,786 | -2,711 | -3,560 | -3,485 | -2,265 | -3,499 | -3,318 | -4,284 |
| Total shareholders’ equity | 53,230 | 52,063 | 50,416 | 50,822 | 50,212 | 50,872 | 51,602 | 52,722 | 51,665 | 50,420 | 48,256 |
| Noncontrolling interests | - | - | 122 | 102 | 121 | 135 | 174 | 171 | 182 | 206 | 232 |
| Total equity | - | - | 50,416 | 50,822 | 50,212 | 50,872 | 51,602 | 52,722 | 51,665 | 50,420 | 48,256 |
| Total liabilities and equity | 106,685 | 99,782 | 99,816 | 91,393 | 89,694 | 90,689 | 93,083 | 90,981 | 90,948 | 89,981 | 91,680 |